diltiazem hydrochloride 30 MG Oral Tablet [Cardizem]
diltiazem hydrochloride
RxCUI: 833219
What the CMS Formulary Data Shows for diltiazem hydrochloride 30 MG Oral Tablet [Cardizem]
Per the CMS 2026 Part D formulary file, diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] (RxNorm concept RXCUI 833219, generic name diltiazem hydrochloride) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 965,356 Part D beneficiaries filled diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] in 2023, with total plan-and-beneficiary spending of $157,172,185 and an average per-beneficiary annual cost of $162.81. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 965,356
- Total spending
- $157,172,185
- Avg per beneficiary
- $162.81
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering diltiazem hydrochloride 30 MG Oral Tablet [Cardizem]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] covered by Medicare Part D?
Yes, diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] on Medicare Part D plans?
diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] require prior authorization?
0% of Part D formularies require prior authorization for diltiazem hydrochloride 30 MG Oral Tablet [Cardizem]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on diltiazem hydrochloride 30 MG Oral Tablet [Cardizem]?
In 2023, total Medicare Part D spending on diltiazem hydrochloride 30 MG Oral Tablet [Cardizem] was $157,172,185, covering 965,356 beneficiaries. The average spend per beneficiary was $162.81.
Read our methodology - how this data is sourced, computed, and verified.